Mitochondrial reprogramming regulates breast cancer progression

Clinical Cancer Research

Volumn 22, Issue 13, 2016, Pages 3348-3360

  Kannan, Anbarasu ^a   Wells, Robert B ^a   Sivakumar, Subramaniam ^b   Komatsu, Satoshi ^a   Singh, Karan P ^c   Samten, Buka ^a   Philley, Julie V ^d   Sauter, Edward R ^a   Ikebe, Mitsuo ^a   Idell, Steven ^a   Gupta, Sudeep ^e   Dasgupta, Santanu ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b SRI SANKARA ARTS AND SCIENCE COLLEGE   (India)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d Baylor UT Houston Center for AIDS Research   (United States)

^e TATA MEMORIAL HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME C; MITOFUSIN 2; PEPTIDES AND PROTEINS; SH3GL2 PROTEIN; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE; MFN2 PROTEIN, HUMAN; MITOCHONDRIAL PROTEIN; SH3GL2 PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SUPEROXIDE; TUMOR SUPPRESSOR PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CANCER GROWTH; CANCER INHIBITION; CONTROLLED STUDY; CYTOPLASM; ENDOCYTOSIS; EXOSOME; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; LIVER METASTASIS; LUNG METASTASIS; MITOCHONDRION; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN SECRETION; APOPTOSIS; BREAST TUMOR; CELL PROLIFERATION; DISEASE EXACERBATION; GENETICS; LIVER TUMOR; LUNG TUMOR; MCF-7 CELL LINE; METABOLISM; PATHOLOGY; SECONDARY; SECRETION (PROCESS); TUMOR CELL LINE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; APOPTOSIS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOCHROMES C; DISEASE PROGRESSION; EXOSOMES; FEMALE; GTP PHOSPHOHYDROLASES; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MCF-7 CELLS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; SUPEROXIDES; TUMOR SUPPRESSOR PROTEINS;

EID: 84977071272     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-15-2456     Document Type: Article

References (50)

1. Eccles SA, Aboagye EO, All S, Anderson AS, Armes J, Berditchevski F, et al. Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer. Breast Cancer Res 2013;15:R92.
2. National Cancer Institute. Available from: www.cancer.gov.
3. Polyak K. Breast cancer: origin and evolution. J Clin Invest 2007;117:3155-63.
4. Dos Anjos Pultz B, da Luz FA, de Faria PR, Oliveira AP, de Araújo RA, Silva MJ. Far beyond the usual biomarkers in breast cancer: a review. J Cancer 2014;5:559-71.
5. Bombonati A, Sgori DC. The molecular pathology of breast cancer progression. J Pathol 2011;223:310-317.
6. Archer SL. Mitochondrial dynamics- mitochondrial fission and fusion in human diseases. New Eng J Med 2013;369:2236-51.
7. He Y, Wu J, Dressman DC, Iacobuzio-Donahue C, Markowitz SD, Velculescu VE, et al. Heteroplasmic mitochondrial DNA mutations in normal and tumour cells. Nature 2010;464:610-14.
8. Boland ML, Chourasia AH, Macleod KF. Mitochondrial dysfunction in cancer. Front Oncol 2013;3:1-18.
9. Da silva AF, Mariotti FR, Maximo V, Campello S. Mitochondria dynamism: of shape, transport and cell migration. Cell Mol Life Sci 2014;71:2313-24.
10. Azmi AS, Bao B, Sarkar FH. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review. Cancer Metastasis Rev 2013;32:623-42.
11. Kahlert C, Kalluri R. Exosomes in tumor microenvironment influence cancer progression and metastasis. J Mol Med 2013;91:431-37.
12. Melo SA, Sugimoto H, O'Connell JT, Kato N, Villanueva A, Vidal A, et al. Cancer Exosomes Perform Cell-Independent MicroRNA Biogenesis and Promote Tumorigenesis. Cancer Cell 2014;26:707-21.
13. Kjaerulff O, Brodin L, Jung A. The structure and function of endophilin proteins. Cell Biochem Biophys 2011;60:137-54.
14. Dasgupta S, Menezes ME, Das SK, Emdad L, Janijic A, Bhatia S, et al. Novel role of MDA-9/syntenin in regulating urothelial cell proliferation by modulating EGFR signaling. Clin Cancer Res 2013;19:4621-33.
15. Oyesanya RA, Bhatia S, Menezes ME, Dumur CI, Singh KP, Bae S, et al. MDA-9/Syntenin regulates differentiation and angiogenesis programs in head and neck squamous cell carcinoma. Oncoscience 2014;1:725-37.
16. Iorns E, Drews-Elger K, Ward TM, Dean S, Clarke J, Berry D, et al. A new mouse model for the study of human breast cancer metastasis. PLoS One 2012;7:e4799.
17. Sinha S, Chunder N, Mukherjee N, Alam N, Roy A, Roychoudhury S, et al. Frequent deletion and methylation in SH3GL2 and CDKN2A loci are associated with early- and late-onset breast carcinoma. Ann Surg Oncol 2008;15:1070-80.
18. Dasgupta S, Hoque MO, Upadhyay S, Sidransky D. Forced Cytochrome B gene mutation expression induces mitochondrial proliferation and prevents apoptosis in human uroepithelial SV-HUC-1 cells. Int J Cancer 2009;125:2829-35.
19. O'Flanagan CH, O'Neill C. PINK1 signaling in cancer biology. Biochim Biophys Acta 2014;1846:590-8.
20. Onder TT, Gupta PB, Mani SA, Yang J, Lander ES, Weinberg RA, et al. Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways. Cancer Res 2008;68:3645-54.
21. Berx G, Van Roy F. The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 2001;3:289-93.
22. Lu H, Li G, Liu L, Wang X, Jin H. Regulation of and function of mitophagy in development and cancer. Autophagy 2013;9:1720-36.
23. Gomes LC, Scorrano L. Mitochondrial morphology in mitophagy and macroautophagy. Biochim Biophys Acta 2013;1833:205-12.
24. Dolman NJ, Chambers KM, Mandavilli B, Batchelor RH, Janes MS. Tools and techniques to measure mitophagy using fluorescence microscopy. Autophagy 2013;9:1653-62.
25. Zhu J, Wang ZQ, Chu CT. Mitochondrial biogenesis, mitophagy and cell survival. Autophagy 2013;9:1663-76.
26. Gabrielson M, Bjorklund M, Carlson J, Shoshan M. Expression of mitochondrial regulators pgc-1a and tfam as putative markers of subtype and chemoresistance epithelial ovarian carcinoma. PLoS One 2014;9:e107109.
27. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr, Kinzler KW. Cancer genome landscapes. Science 2013;339:1546-58.
28. American Cancer Society. Available from: http://www.cancer.org/cancer/breastcancer/moreinformation/breastcancerearlydetection/breast-cancer-early-detection-toc.
29. Susan G. Komen for the Cure. Available from: http://ww5.komen.org/AboutBreastCancer/ScreeningandEarlyDetection/ScreeningTestsandDiagnosticTools/ScreeningTestsDiagnosticTools.html
30. Hirata BKB, Oda JMM, Guembarovski RL, Ariza CB, Coral de Oliveira CE, Watanabe MA. Molecular markers for breast cancer: prediction on tumor behavior. Dis Markers 2014;2014:513158.
31. Wang WJ, Lei YY, Mei JH, Wang CL. Recent progress in HER2 associated breast cancer. Asian Pac J Cancer Prev 2015;16:2591-600.
32. Polyak K, Filho OM. Snapshots: breast cancer. Cancer Cell 2012;22:562.
33. Dasgupta S, Jang JS, Shao C, Mukhopadhyay ND, Sokhi UK, Das SK, et al. SH3GL2 is frequently deleted in non-small cell lung cancer and downregulates tumor growth by modulating EGFR signaling. J Mol Med 2013;91:381-93.
34. Majumdar S, Gong EM, Di Vizio D, Dreyfuss J, Degraff DJ, Hager MH, et al. Loss of Sh3gl2/endophilin A1 is a common event in urothelial carcinoma that promotes malignant behavior. Neoplasia 2013;15:749-60.
35. Gomes LC, Scorrano L. Mitochondrial morphology in mitophagy and macroautophagy. Biochim Biophys Acta 2013;1833:205-12.
36. Rehman J, Zhang HJ, Toth PT, Zhang Y, Marsboom G, Hong Z, et al. Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J 2012;26:2175-86.
37. Jin B, Fu G, Pan H, Cheng X, Zhou L, Lv J, et al. Anti-tumor efficacy of mitofusin-2 in urinary bladder carcinoma. Med Oncol 2011;28 Suppl 1:S373-S380.
38. Wang W, Lu J, Zhu F, Wei J, Jia C, Zhang Y, et al. Pro-apoptotic and anti-proliferative effects of mitofusin-2 via bax signaling in hepatocellular carcinoma cells. Med Oncol 2012;29:70-6.
39. Wang W, Xie Q, Zhou X, Yao J, Zhu X, Huang P, et al. Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in hepatocellular carcinoma cells. Cancer Lett 2015;358:47-58.
40. Zhang GE, Jin HL, Lin XK, Chen C, Liu XS, Zhang Q, et al. Anti-tumor effects of mfn2 in gastric cancer. Int J Mol Sci 2013;14:13005-21.
41. Cheng X, Zhou D, Wei J, Lin J. Cell-cycle arrest at G2/M and proliferation inhibition by adenovirus-expressed mitofusin-2 gene in human colorectal cancer cell lines. Neoplasma 2013;60:620-26.
42. Zhao J, Zhang J, Yu M, Xie Y, Huang Y, Wolff DW, et al. Mitochondrial dynamics regulates migration and invasion of breast cancer cells. Oncogene 2013;32:4814-24.
43. Luo S, Rubinszztein DC. Atg5 and bcl-2 provide novel insight into the interplay between apoptosis and autophagy. Cell Death Differ 2007;14:1247-50.
44. Wang L, Yao L, Zheng YZ, Xu Q, Liu XP, Hu X, et al. Expression of autophagy-related proteins atg5 and fip200 predicts favorable disease-free survival in patients with breast cancer. Biochem Biophys Res Commun 2015;458:816-22.
45. Lindberg ME, Stodden GR, King ML, MacLean JA 2nd, Mann JL, DeMayo FJ, et al. Loss of CDH1 and Pten accelerates cellular invasiveness and angiogenesis in the mouse uterus. Biol Reprod 2013;89:8.
46. Guo J, Zheng L, Liu W, Wang X, Wang Z, Wang Z, et al. Frequent truncating mutation of TFAM induces mitochondrial DNA depletion and apoptotic resistance in microsatellite-unstable colorectal cancer. Cancer Res 2011;71:2978-87.
47. Brenner AJ, Aldaz CM. Cancer Res. Chromosome 9p allelic loss and p16/CDKN2 in breast cancer and evidence of p16 inactivation in immortal breast epithelial cells. Cancer Res 1995;55:2892-95.
48. Baietti MF, Zhang Z, Mortier E, Melchior A, Degeest G, Geeraerts A, et al. Syndecan-syntenin-ALIX regulates the biogenesis of exosomes. Nat Cell Biol 2012;14:677-85.
49. Tomlinson PR, Zheng Y, Fischer R, Heidasch R, Gardiner C, Evetts S, et al. Identification of distinct circulating exosomes in Parkinson's disease. Ann Clin Transl Neurol 2015;2:353-61.
50. Philley JV, Kannan A, Dasgupta S. MDA-9/Syntenin control. J Cell Physiol 2016;231:545-50.